Sumatriptan, a selective serotonin receptor (5-HT1B/1D) agonist, rapidly constricts cerebral blood vessels and inhibits neuropeptide release, providing fast-acting relief from acute cluster headache symptoms. When administered subcutaneously, it quickly reduces pain intensity and associated autonomic symptoms by targeting neurovascular mechanisms in the trigeminal system.